← Back to Clinical Trials
Recruiting NCT07520734

NCT07520734 Clinical Outcomes After Laser Hemorrhoidoplasty

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07520734
Status Recruiting
Phase
Sponsor Sanliurfa Education and Research Hospital
Condition Hemorrhoidal Disease
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2026-06-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Laser Hemorrhoidoplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2026-06-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Symptomatic internal hemorrhoidal disease * Scheduled to undergo laser hemorrhoidoplasty * Willingness to participate and provision of informed consent Exclusion Criteria: * Grade IV hemorrhoidal disease * Acute thrombosed hemorrhoids * Additional anorectal pathology such as anal fissure, fistula, or perianal abscess * History of inflammatory bowel disease or colorectal malignancy * Previous major anal surgery'

Contact & Investigator

Central Contact

Vedat Kaplan, MD

✉ vedat_kaplan_@hotmail.com

📞 +905459045165

Principal Investigator

Vedat Kaplan

PRINCIPAL INVESTIGATOR

Sanliurfa Education and Research Hospital

Frequently Asked Questions

Who can join the NCT07520734 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hemorrhoidal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07520734 currently recruiting?

Yes, NCT07520734 is actively recruiting participants. Contact the research team at vedat_kaplan_@hotmail.com for enrollment information.

Where is the NCT07520734 trial being conducted?

This trial is being conducted at Sanliurfa, Turkey (Türkiye).

Who is sponsoring the NCT07520734 clinical trial?

NCT07520734 is sponsored by Sanliurfa Education and Research Hospital. The principal investigator is Vedat Kaplan at Sanliurfa Education and Research Hospital. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology